… Treatment with cladribine leads to a preferential reduction in lymphocytes, resulting in …
depletion It is approved for treatment of relapsing multiple sclerosis (MS). Cladribine tablets 3.5 mg…

… Because of animal studies showing teratogenicity and embryotoxicity, … pregnancy or in
women of childbearing potential not on effective contraception. In cases of unplanned pregnancy …

… Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance
of natural killer cells. Clin Exp Immunol 2008;151(2):235-43. 10. Braunwald E, Fauci AS, …

… Multiple Sclerosis (MS) is a chronic disease affecting around 2.8 million people worldwide.
Two-thirds are women, and … older age at first pregnancy, both in women with and without MS. …

… that pregnancy modulates the course of multiple sclerosis (MS), with a decreased risk of
relapses during pregnancy … , where up to one-third of women relapse in historical cohorts, 1 and …

… Multiple sclerosis (MS) is more prevalent in women than in men. The sex of the patient, and
pregnancy, are reported to be associated with the clinical features of MS. The mechanism of …

… A female predominance in relapsing multiple sclerosis (RMS) is well known with a female:
male ratio of 2.3–3.5:1 which even showed an increase in the last decades [1, …

… Multiple sclerosis (MS) is an immune system disorder that affects the central nervous system
(CNS) and progressively damages nerve fibers and protective myelin. People with MS often …

… rates (LBRs) and infertility in women with multiple sclerosis (MS) are lacking. This study
compared LBRs, infertility diagnoses, and infertility treatments in women with and without MS. …

… studies was a few hundred patients, however, and we believe that our results are more robust
due to the nationwide study … We found that AEs, disease activity and pregnancy were the …